Acetaminophen or Nonsteroidal Anti-Inflammatory Drugs in Acute Musculoskeletal Trauma: A Multicenter, Double-Blind, Randomized, Clinical Trial

被引:22
作者
Ridderikhof, Milan L. [1 ]
Lirk, Philipp [2 ,8 ]
Goddijn, Helma [1 ]
Vandewalle, Edwin [6 ]
Schinkel, Erik
Van Dieren, Susan [3 ]
Kemper, Marleen [4 ]
Hollmann, Markus W. [2 ]
Goslings, J. Carel [5 ,7 ]
机构
[1] Acad Med Ctr, Dept Emergency Med, Amsterdam, Netherlands
[2] Acad Med Ctr, Dept Anesthesiol, Amsterdam, Netherlands
[3] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands
[4] Acad Med Ctr, Hosp Pharm, Amsterdam, Netherlands
[5] Acad Med Ctr, Dept Trauma Surg, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam Med Ctr, Dept Emergency Med, Amsterdam, Netherlands
[7] Onze Lieve Vrouw Hosp, Dept Trauma Surg, Amsterdam, Netherlands
[8] Brigham & Womens Hosp, Dept Anesthesiol, 75 Francis St, Boston, MA 02115 USA
关键词
ANKLE SPRAINS; EMERGENCY-DEPARTMENT; NSAID USE; PAIN; PARACETAMOL; RISK; COMBINATION; IBUPROFEN; EFFICACY; DICLOFENAC;
D O I
10.1016/j.annemergmed.2017.08.041
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: We determine whether pain treatment with acetaminophen was not inferior to nonsteroidal anti-inflammatory drugs or the combination of both in minor musculoskeletal trauma. Methods: The Paracetamol or NSAIDs in Acute Musculoskeletal Trauma Study was a double-blind, randomized, clinical trial conducted in 2 general practices and 2 emergency departments in the Netherlands. A total of 547 adults, aged 18 years and older, with acute blunt minor musculoskeletal extremity trauma were randomly assigned in a 1:1:1 ratio to acetaminophen 4,000 mg/day, diclofenac 150 mg/day, or acetaminophen 4,000 mg/day+diclofenac 150 mg/day during 3 consecutive days. Patients, health care staff, and outcome assessors were blinded for treatment allocation. Follow-up for each patient was 30 days. Primary outcome measures were between-group differences in mean numeric rating scale (NRS) pain scores in rest and with movement at 90 minutes after initial drug administration compared with baseline pain scores with a predefined noninferiority margin of 0.75 NRS points. Secondary outcomes included NRS pain scores during 3 consecutive days and need for additional analgesia. Results: One hundred eighty-two patients were treated with acetaminophen, 183 with diclofenac, and 182 with combination treatment. Intention-to-treat analysis revealed mean NRS reduction in rest -1.23 (95% confidence interval [CI] -1.50 to -0.95) and -1.72 (95% CI -2.01 to -1.44) with movement, both for acetaminophen at 90 minutes compared with baseline. Pairwise comparison in rest with diclofenac showed a difference of -0.027 (97.5% CI -0.45 to 0.39) and -0.052 (97.5% CI -0.46 to 0.36) for combination treatment. With movement, these numbers were -0.20 (97.5% CI -0.64 to 0.23) and -0.39 (97.5% CI -0.80 to 0.018), respectively. All differences were well below the predefined noninferiority margin. Conclusion: Pain treatment with acetaminophen was not inferior to that with diclofenac or the combination of acetaminophen and diclofenac in acute minor musculoskeletal extremity trauma, both in rest and with movement.
引用
收藏
页码:357 / 368
页数:12
相关论文
共 32 条
[1]  
[Anonymous], J PHARM PRACTICE
[2]  
Bijur PE, 2003, ACAD EMERG MED, V10, P390, DOI 10.1197/aemj.10.4.390
[3]   Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial [J].
Bondarsky, Eric E. ;
Domingo, Anna T. ;
Matuza, Nicholas M. ;
Taylor, Maria B. ;
Thode, Henry C., Jr. ;
Singer, Adam J. .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (09) :1357-1360
[4]   Review of sports injuries presenting to an accident and emergency department [J].
Boyce, SH ;
Quigley, MA .
EMERGENCY MEDICINE JOURNAL, 2004, 21 (06) :704-706
[5]   Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains [J].
Dalton, James D., Jr. ;
Schweinle, Jo Ellen .
ANNALS OF EMERGENCY MEDICINE, 2006, 48 (05) :615-623
[6]   Core outcome measures for chronic pain clinical trials: IMMPACT recommendations [J].
Dworkin, RH ;
Turk, DC ;
Farrar, JT ;
Haythornthwaite, JA ;
Jensen, MP ;
Katz, NP ;
Kerns, RD ;
Stucki, G ;
Allen, RR ;
Bellamy, N ;
Carr, DB ;
Chandler, J ;
Cowan, P ;
Dionne, R ;
Galer, BS ;
Hertz, S ;
Jadad, AR ;
Kramer, LD ;
Manning, DC ;
Martin, S ;
McCormick, CG ;
McDermott, MP ;
McGrath, P ;
Quessy, S ;
Rappaport, BA ;
Robbins, W ;
Robinson, JP ;
Rothman, M ;
Royal, MA ;
Simon, L ;
Stauffer, JW ;
Stein, W ;
Tollett, J ;
Wernicke, J ;
Witter, J .
PAIN, 2005, 113 (1-2) :9-19
[7]   Non-steroidal anti-inflammatory drugs for chronic low back pain [J].
Enthoven, Wendy T. M. ;
Roelofs, Pepijn D. D. M. ;
Deyo, Richard A. ;
van Tulder, Maurits W. ;
Koes, Bart W. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02)
[8]   Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals [J].
Fosbol, Emil Loldrup ;
Folke, Fredrik ;
Jacobsen, Soren ;
Rasmussen, Jeppe N. ;
Sorensen, Rikke ;
Schramm, Tina Ken ;
Andersen, Soren S. ;
Rasmussen, Soren ;
Poulsen, Henrik Enghusen ;
Kober, Lars ;
Torp-Pedersen, Christian ;
Gislason, Gunnar H. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (04) :395-405
[9]   Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure [J].
Gutthann, SP ;
Rodriguez, LAG ;
Raiford, DS ;
Oliart, AD ;
Romeu, JR .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (21) :2433-2439
[10]  
Harvey R, 1997, PHARM J, V259, P292